Trial Outcomes & Findings for Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms (NCT NCT00778648)

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

543 participants

Primary outcome timeframe

within 6 months (after 2 months run-in period)

Results posted on

2010-10-05

Withdrawal data not reported

Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms

Baseline characteristics by cohort
Measure	Juice Plus n=272 Participants	Placebo n=271 Participants	Total n=543 Participants Total of all reporting groups
Age Continuous	40.9 years STANDARD_DEVIATION 10.2 • n=5 Participants	38.8 years STANDARD_DEVIATION 10.3 • n=7 Participants	40.9 years STANDARD_DEVIATION 10.2 • n=5 Participants
Gender Female	202 participants n=5 Participants	222 participants n=7 Participants	424 participants n=5 Participants
Gender Male	61 participants n=5 Participants	44 participants n=7 Participants	105 participants n=5 Participants
Region of Enrollment Germany	272 participants n=5 Participants	271 participants n=7 Participants	543 participants n=5 Participants

Timeframe: within 6 months (after 2 months run-in period)

Outcome measures
Measure	Juice Plus n=272 Participants	Placebo n=271 Participants
Number of Days With at Least Moderate (i.e. Moderate or Severe) Common Cold Symptoms.	7.6 Number of days Interval 6.5 to 8.8	9.5 Number of days Interval 8.4 to 10.6

Timeframe: Baseline, months 2,4,6,8.

Outcome data not reported

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie , Charité - Universitätsmedizin Berlin, Germany

Phone: +49 30 450 529023